CMS Critiques MADIT-II: “Inducible” Patients Should Have Been Excluded
This article was originally published in The Gray Sheet
Executive Summary
CMS' Medicare Coverage Advisory Committee will consider whether MADIT-II's inclusion of 210 patients with known ventricular arrhythmia undermines investigator claims for prophylactic ICD use in patients without inducible ventricular tachyarrythmias (VT)
You may also be interested in...
MCAC Supports MADIT-II Criteria; EP Testing Scuttled As Stratification Tool
Guidant's subgroup analysis demonstrating that non-inducible EP-tested patients showed lower mortality rates with ICDs over conventional therapy played a decisive factor in MCAC's endorsement of national coverage
MCAC Supports MADIT-II Criteria; EP Testing Scuttled As Stratification Tool
Guidant's subgroup analysis demonstrating that non-inducible EP-tested patients showed lower mortality rates with ICDs over conventional therapy played a decisive factor in MCAC's endorsement of national coverage
Prophylactic ICD Cost Considerations: Will They Upstage MCAC Data Review?
CMS' referral to the Medicare Coverage Advisory Committee of a national coverage determination for an expanded ICD indication raises the bar for the type of clinical evidence needed to secure reimbursement